Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2423-2425

  Conde, Diego ^a   Costabel, Juan Pablo ^a   Caro, Milagros ^a   Ferro, Alejandra ^a   Lambardi, Florencia ^a   Corrales Barboza, Andrea ^a   Cobo, Augusto Lavalle ^a   Trivi, Marcelo ^a  

^a INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

Author keywords

Atrial fibrillation; Flecainide; Vernakalant

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FLECAINIDE; PROPAFENONE; VERNAKALANT; ANISOLE DERIVATIVE; ANTIARRHYTHMIC AGENT; PYRROLIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; DEATH; DIZZINESS; DRUG TOLERABILITY; DYSGEUSIA; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; MALE; NAUSEA; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SINGLE DRUG DOSE; SINUS RHYTHM; TASTE DISORDER; TREATMENT RESPONSE; ATRIAL FIBRILLATION; COMPARATIVE STUDY; MIDDLE AGED; TIME;

AGED; ANISOLES; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; FLECAINIDE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLIDINES; TIME FACTORS;

EID: 84885673406     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.02.006     Document Type: Article

References (14)

1. A. Go, E. Hylek, and K. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. J. Friberg, P. Buch, H. Scharling, N. Gadsbphioll, and G. Jensen Rising rates of hospital admissions for atrial fibrillation Epidemiology 14 2003 666 672
3. H. Li, A. Easley, W. Barrington, and J. Windle Evaluation and management of atrial fibrillation in the emergency department Emerg Med Clin North Am 16 1998 389 403
4. P. Zimetbaum Antiarrhythmic drug therapy for atrial fibrillation Circulation 125 2012 381 389
5. V. Fuster, L. Rydén, and D. Cannom ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 e269 e367
6. A. Camm, G. Lip, and R. De Caterina Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
7. D. Roy, B. Rowe, and I. Stiell A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation J Am Coll Cardiol 44 2004 2355 2361
8. D. Roy, C. Pratt, and C. Torp-Pedersen Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial Circulation 117 12 Mar 25 2008 1518 1525
9. A.J. Camm, A. Capucci, and S.H. Hohnloser A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation J Am Coll Cardiol 57 2011 313 321
10. P. Kowey, P. Dorian, and L. Mitchell Vernakalant hydrochloride for rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double blind, placebo-controlled trial Circ Arrhythm Electrophysiol 2 2009 652 659
11. A.H. Madrid, C. Moro, E. Marín-Huerta, J.L. Mestre, L. Novo, and A. Costa Comparison of flecainide and procainamide in cardioversion of atrial fibrillation Eur Heart J 14 8 Aug 1993 1127 1131
12. A. Capucci, G. Boriani, and G.L. Botto Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide Am J Cardiol 74 5 Sep 1 1994 503 505
13. I.A. Khan Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation J Am Coll Cardiol 37 2 Feb 2001 542 547
14. P. Alboni, G.L. Botto, and G. Boriani Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment Heart 96 7 Apr 2010 546 549